Lung adenocarcinoma subtypes based on expression of human airway basal cell genes

European Respiratory Journal

Volumn 42, Issue 5, 2013, Pages 1332-1344

  Fukui, Tomoya ^a   Shaykhiev, Renat ^a   Agosto Perez, Francisco ^b   Mezey, Jason G ^a,b   Downey, Robert J ^c   Travis, William D ^c   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Program on Infrastructure Policy   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; AMPHIREGULIN; ANTINEOPLASTIC AGENT; CYTOKERATIN 17; CYTOKERATIN 5; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; INTERSTITIAL COLLAGENASE; K RAS PROTEIN; MAMMAGLOBIN B; NERVE CELL ADHESION MOLECULE; PLACENTA PROTEIN 5; PROTEIN P53; THYROID TRANSCRIPTION FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D RECEPTOR;

AGED; ARTICLE; BASAL CELL; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER SURVIVAL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLARA CELL; COMORBIDITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDUCTION CHEMOTHERAPY; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CANCER; LUNG CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; OVERALL SURVIVAL; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL TIME; TRANSCRIPTION INITIATION; TUMOR INVASION; TUMOR VOLUME; UPREGULATION;

ADENOCARCINOMA; AGED; BIOPSY; CELL DIFFERENTIATION; COHORT STUDIES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, BASAL CELL; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PROPORTIONAL HAZARDS MODELS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTOME;

EID: 84887269387     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00144012     Document Type: Article

References (36)

1. Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol 2006; 1: 331-348.
2. Jemal A, Siegel R, Xu J, et al. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359: 1367-1380.
4. Crystal RG, Randell SH, Engelhardt JF, et al. Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc 2008; 5: 772-777.
5. Rock JR, Onaitis MW, Rawlins EL, et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA 2009; 106: 12771-12775.
6. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and genetics: tumors of the lung, pleura, thymus and heart. Lyon, IARC, 2004.
7. Yatabe Y. EGFR mutations and the terminal respiratory unit. Cancer Metastasis Rev 2010; 29: 23-36.
8. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-285.
9. Pack RJ, Al-Ugaily LH, Morris G. The cells of the tracheobronchial epithelium of the mouse: A quantitative light and electron microscope study. J Anat 1981; 132: 71-84.
10. Boers JE, Ambergen AW, Thunnissen FB. Number and proliferation of clara cells in normal human airway epithelium. Am J Respir Crit Care Med 1999; 159: 1585-1591.
11. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-835.
12. Ooi AT, Mah V, Nickerson DW, et al. Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. Cancer Res 2010; 70: 6639-6648.
13. Hackett NR, Shaykhiev R, Walters MS, et al. The human airway epithelial basal cell transcriptome. PLoS One 2011; 6: e18378.
14. Chitale D, Gong Y, Taylor BS, et al. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFRmutant tumors. Oncogene 2009; 28: 2773-2783.
15. Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006; 439: 353-357.
16. Shedden K, Taylor JM, Enkemann SA, et al. Gene expression-based survival prediction in lung adenocarcinoma: A multi-site, blinded validation study. Nat Med 2008; 14: 822-827.
17. Bryant CM, Albertus DL, Kim S, et al. Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study. PLoS One 2010; 5: e11712.
18. Smith JJ, Deane NG, Wu F, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010; 138: 958-968.
19. Lu X, Lu X, Wang ZC, et al. Predicting features of breast cancer with gene expression patterns. Breast Cancer Res Treat 2008; 108: 191-201.
20. Kuner R, Muley T, Meister M, et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 2009; 63: 32-38.
21. Hou J, Aerts J, den HB, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010; 5: e10312.
22. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069-1075.
23. Chiang DY, Villanueva A, Hoshida Y, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008; 68: 6779-6788.
24. Badea L, Herlea V, Dima SO, et al. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 2008; 55: 2016-2027.
25. Tilley AE, O'Connor TP, Hackett NR, et al. Biologic phenotyping of the human small airway epithelial response to cigarette smoking. PLoS One 2011; 6: e22798.
26. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
27. UICC. TNM Classification of Malignant Tumors. 6th Edn. New York, Wiley-Liss Inc., 2002.
28. Visvader JE. Cells of origin in cancer. Nature 2011; 469: 314-322.
29. Camilo R, Capelozzi VL, Siqueira SA, et al. Expression of P63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas. Hum Pathol 2006; 37: 542-546.
30. Rock JR, Randell SH, Hogan BL. Airway basal stem cells: A perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech 2010; 3: 545-556.
31. Quinlan MP, Quatela SE, Philips MR, et al. Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion. Mol Cell Biol 2008; 28: 2659-2674.
32. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
33. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
34. Filosto S, Becker CR, Goldkorn T. Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors. Mol Cancer Ther 2012; 11: 795-804.
35. Horiuchi D, Kusdra L, Huskey NE, et al. MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. J Exp Med 2012; 209: 679-696.
36. Coraux C, Roux J, Jolly T, et al. Epithelial cell-extracellular matrix interactions and stem cells in airway epithelial regeneration. Proc Am Thorac Soc 2008; 5: 689-694.